MPP invites Expressions of Interest (EoI) from potential sublicensees based anywhere in the world for sublicences to manufacture and sell the cabotegravir long-acting injectable in the licensed territory.

GENEVA, SWITZERLAND / AGILITYPR.NEWS / May 20, 2022 / The Union for International Cancer Control (UICC) and multiple partners* are establishing the Access to Oncology Medicines (ATOM) Coalition, a new global partnership to increase access to quality-assured essential cancer medicines in low- and lower middle-income countries (LLMICs) and to help countries develop the capacity for their proper use.

The newly established IGBA CEO Advisory Committee, a forum for generic and biosimilar medicines industry leaders to discuss broad, strategic issues, and to engage and position the industry on a range of critical policy matters, held its inaugural meeting on Monday, May 2 and launched initial discussions with World Trade Organization (WTO) Director-General Dr. Ngozi Okonjo-Iweala.